Clarity Medical Group Holding Limited provided earnings guidance for the year ended 31 March 2023. For the year, the Company is expected to record a loss before tax in a range of approximately HKD 4.9 million to HKD 5.4 million for the year ended 31 March 2023 as compared to the position of an adjusted profit before tax of HKD 37.2 million for the year ended 31 March 2022. The expected turnaround is primarily due to the expected decrease in revenue and increase in administrative expenses.

Due to the economic downturn and increased competition from other industry players, the Group adopted a more competitive pricing strategy during the year ended 31 March 2023 which had affected the Group's revenue.